Image

POST-TREATMENT:
LENITIVE HA+PFD+PA

HYALURONIC ACID + PERFLUORODECALIN + PHYSALIS ANGULATA

Image

Sterile

Registered as cosmetic

With ReadyMedical Post-Treatment the pratictioner mixes sterile sonicated Hyaluronic Acid with a combination of sterile Perfluorodecalin and Physalis Angulata Extract to sooth inflamed skin after chemical and mechanical peels, dermabrasion, CO2, Q-switched, Erbium and Nd:YAG lasers. By administering RM Post-Treatment a strong hydrating and moisturizing treatment is also provided.

PROVIDES A STRONG LENITIVE ACTION FOR POST-INVASIVE PROCEDURES, ERITHEMA AND SCARRING

Decreases intradermical microinflammation

Regulates intradermal temperature Increases serine proteases, maintaining and repairing skin collagen

POST - TREATMENT: LENITIVE HA + PFD + PA

BEFORE & AFTER

recommended combined protocols

How to use:
Apply ReadyMedical Post-Treatment immediately after the treatment to reduce inflammation and boost the results

TREATMENT/TECHNOLOGY & ACTION

** CO2 Laser Nd:YAG Laser Erbium Laser Q-switched Laser

As demonstrated by a University Study, RM Post- Treatment reduces inflammation by 94%, it is therefore the most recommended product to be applied immediately after a laser session. It provides faster recovery from bleeding wounds and an immediate reduction of skin burning sensation

*Dermaroller, Dermapen

After a strong invasive or medium-invasive procedure, applied in total safety even on bleeding areas, RM Post-Treatment provides a faster wound repair and significantly decreases healing time

*Strong Chemical Peeling, Dermabrasion

Applied after a strong chemical peeling RM Post-Treatment decreases inflammation and redness, plus it provides strong hydration and an anti-aging effect

* It is recommended to apply another RM Post-Treatment during the following 24 h
** It is highly recommended to apply 2 RM Post-Treatment during the following 48 h

EFFICACY STUDY ON THE ANTI-INFLAMMATORY ACTIVITY OF READYMEDICAL POST-TREATMENT: LENITIVE HA+PFD+PA

The study has been conducted through the in vitro evaluation of the anti-inflammatory activity of ReadyMedical HA+PFD+PA (1) on human fibroblasts.
A human keratinocyte cell line has been treated with this special compound of sonicated Hyaluronic Acid + Perfluorodecalin + Physalis Angulata. The treated cells showed a decrease of ~ 94% of inflammation compared to the untreated cells used as negative control.
The anti-inflammatory activity has been calculated measuring the IL-8 levels 24 hours after treating the fibroblasts with the product; the result was a decrease of the IL-8 levels between 93,25% and 94,82%, compared to the untreated cells.
IL-8 is the most direct and reliable marker of inflammation among the wide cytokine family. Cytokines are small proteins known to play an important role in the immune system; in particular they are able to influence the activation, maturation, growth and differentiation of several cell populations. IL-8 secretion is particularly active in chronic inflammation conditions, thus measurement of this cytokine in an in vitro model, composed by fibroblasts, represents a useful and sensitive tool to assess the anti-inflammatory effect of a topical product.

1) UB-CARE – UNIVERSITY OF PAVIA. Report nr. AIF/17/LC1/P1. Date: 12/07/2017. The full version of this study is available upon request.

Image
Image
Image

ReadyMedical is a registered trademark of :

Image
Image
Image

ReadyMedical is the first professional line of ready to mix sterile cosmetic products specifically created for Physicians and for pratictioners in the field of aesthetics.

Contact Us

Jet Tech Europe Srl
Via G. Silvestri, 15
20126 Milano (Italy)
Phone: +39 02 954 205 385
Email: info@readymedical.it

 facebook  Instagram  linkedin

Please select your
Country / Geographic Area
Veuillez sélectionner votre pays / zone géographique